loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Marketing Authorisations (MA) containing Prestwick3_000276 in Europe. Original Data : EMA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 2care4 (1)

02 Farm Agon (1)

03 LEO Pharma (4)

04 LEO Pharma AB (2)

05 Orifarm AS (3)

filter

01 Bumetanide (9)

02 bumetanide (2)

filter

01 Antic-calc Tablet (8)

02 Injection fluid, resolution (1)

03 SOLUTION FOR INJECTION (1)

04 TABLET (1)

filter

01 Norway (9)

02 Sweden (2)

filter

01 Burinex (11)

URL Supplier Web Content
TABLET
1 MG
Burinex
Sweden
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION FOR INJECTION
0.5 MG / ML
Burinex
Sweden
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Injection fluid, resolution
0.5 mg/ml
Burinex
Ampoule
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
1 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
2 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
5 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
1 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Antic-calc Tablet
1 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Farm Agon

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
Antic-calc Tablet
1 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

2care4

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
Antic-calc Tablet
1 mg
Burinex
Blister
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY